The Edge Drug List is an up-to-date list of medications a patient is using. The goal is to gradually achieve this national drug list before 2030. The introduction of the drug list makes it possible to provide current information about drug therapy to the patient, which contributes to the success of drug therapy and improves patient safety. The team’s draft is ready for consultation until 14.4.222.
In accordance with the government program of the government of Prime Minister Sanna Marin, the long-term reform of drug supply will be carried out according to the roadmap contained in the report of the Ministry of Social Affairs and Health (2019:5). The legal changes that the Kanta Drug List assumes were previously set up as service assignments as part of the development of information management and digital tools in substance abuse treatment.
The government bill was prepared in two stages. In the first stage, a bill was prepared with a proposal for a law on the processing of customer data in social and health care and for certain laws related to it. The bill was submitted for consultation and the consultation period expired on March 18, 2022.
The bill now being sent for consultation also includes changes that apply to the Kanta drug list. The changes affect the e-prescription law and the proposed law on the processing of customer data in the field of social and health care. The changes will make it possible to create a list of medications that have been prescribed to a patient in the open healthcare system. At a later time, changes to the law will be implemented that make it possible to use the list of medicines in social care and that give the patient the opportunity to add self-care medicines to the list of medicines. The list of medicines will later be expanded to include, in addition to medicines used in outpatient healthcare, also medicines that have been used in connection with care on the ward.
Prescriptions must be defined as medical records and the drug list must be compiled based on information stored in the prescription center.
Legislation on prescriptions is currently separate from other legislation on medical records. Prescriptions are entered into the patient data system and stored in the prescription center, while other data about drug therapy is entered into the patient data archive. This means that different data layers may contain different data on the drugs a patient is using, compromising reliable and standardized drug data in substance abuse treatment.
In the future, the patient’s prescription information will only be stored in the prescription center, and the prescriptions will be defined as medical records. An up-to-date and comprehensive list of medications used by a patient can be compiled from the prescription data stored in the Prescription Center. The list should look the same for all those involved in the patient’s drug therapy, and should be maintained through prescription notes. In the future, the prescriber will first look at Mina Canta’s drug list to check if the drug information is current, update it and print a new prescription.
The bill also proposes, among other things, a limited right for nurses to change dosing instructions for prescriptions stored in a prescription center and changes to a patient’s right to block. Currently, the notes for nurses in the Prescribing Center are not updated, which means that the patient data archive and the Prescribing Center may contain conflicting information on dosage.
Tina Satie, lawyer, [email protected] (Legislative changes related to the drug list)
Anna Kräkkanen, specialist, [email protected] (Legislative changes related to the drug list)
Ari Jansen, specialist, [email protected] (Legislative changes related to the drug list)
Johnny Kumulainen, Government Adviser, [email protected] (Government bill in its entirety)